Skip to main content

Search Results

Disease Registries and Other Disease Studies

Not sure what a disease registry is? A disease registry collects, manages and analyzes information on patients with a particular diagnosis over time, including blood and tissue samples, blood counts, symptoms, treatments, medical history and family medical history. The information collected helps researchers develop new therapies. Registries often contact patients on a regular basis to monitor their illness.

#ASCO20: Cancer in the Time of COVID-19, and Progress in Myeloma and Lymphoma

As National Cancer Research Month (May) winds down, it seems timely to reflect on progress in cancer treatments. And that is precisely what we will do this weekend.

Pregnancy & Cancer Registry

To collect information about the diagnosis and treatment of cancer in pregnancy, and to study the health of pregnant women with a history of cancer and their children.

  • Gathers information about cancer found and treated during pregnancy at various hospitals into a single database.
  • Designed to follow women and their children through diagnosis, treatment, delivery, childhood, adolescence and beyond.

Pregnant women with cancer, caregivers, survivors, health professionals

877-635-4499 http://www.cancerandpregnancy.com/
Support and Counseling
Fertility and Pregnancy

Cord Blood Registry

To advance the clinical application of newborn stem cells by partnering with leading research institutions to establish FDA-regulated clinical trials, exclusive to CBR families, for conditions that have no cure today.

  • Newborn Possibilities Program® offers free cord blood and tissue processing and five years of storage to qualifying families in the U.S.
  • Genetic counselors are available to discuss your family’s medical history and to answer questions about how newborn stem cells might be applicable to your family.

Patients, families, caregivers

888.CORD.BLOOD or 888.932.6568 http://www.cordblood.com/benefits-cord-blood/family-cord-bloods

LGL Leukemia Registry at UVA

To learn more about this rare form of blood cancer and how to treat it.

  • Based at the University of Virginia Cancer Center in Charlottesville, under the direction of Thomas P. Loughran, Jr, MD
  • Participation in the registry is voluntary. Patients will be studied over time to learn more about the disease.
  • Patients will need to complete questionnaires and provide blood and tissue samples; these samples may be used to develop new tests or treatments.

Anyone diagnosed with Large Granulocytic Lymphocyte (LGL) Leukemia

Website https://uvahealth.com/services/lgl-leukemia-program

Gift of Life Marrow Registry

To facilitate transplantation of volunteer, unrelated donor stem cells as curative therapy for patients around the world of all socioeconomic backgrounds battling leukemia, lymphoma, sickle cell disease and other cancers and genetic diseases. 

  • Provides information on becoming a stem cell or marrow donor
  • Provides information and resources about transplants
  • Provides search process and case management to assist health professionals find donor matches for patients.
     

Gift of Life Marrow Registry is one of the nation’s leading public blood stem cell and bone marrow registries helping children and adults find donors for transplants.

800-962-7769 https://www.giftoflife.org/
Audience
Adults

INTO-HLH: Hemophagocytic Lymphohistiocytosis Disease Registry

INTO-HLH (Insight into the Natural History and Treatment Outcomes of Hemophagocytic Lymphohistiocytosis) is a disease registry aimed at advancing what is known about HLH. The insights obtained from this registry will help doctors to better diagnose and manage HLH and improve treatment outcomes for future patients.

  • INTO-HLH Registry is a collaboration between Cincinnati Children's Hospital Medical Center (CCHMC), Texas Children's Hospital (TCH), and Sobi North America as the industry sponsor.
  • The registry is open to all forms of HLH: Primary; Secondary (Macrophage Activation Syndrome, Cytokine Release Syndrome, Malignancy-Associated HLH).

Patients, family members, and caregivers affected by Hemophagocytic Lymphohistiocytosis and health professionals

Website or (513) 916-7099 https://hlhregistry.org/
International Resources
U.S. Resources

Agency for Toxic Substances & Disease Registry (ATSDR)

ATSDR is directed by congressional mandate to perform specific functions concerning the effect on public health of hazardous substances in the environment. These functions include public health assessments of waste sites, health consultations concerning specific hazardous substances, health surveillance and registries, response to emergency releases of hazardous substances, applied research in support of public health assessments, information development and dissemination, and education and training concerning hazardous substances.

Serves the general public in the U.S. ATSDR is a federal public health agency of the U.S. Department of Health and Human Services

800-232-4636 http://www.atsdr.cdc.gov
researchers

Two Prominent Themes of 2020 Make an Appearance at #ASH20: Covid-19 and Racial Disparities

With the COVID-19 pandemic driving yet another science conference to the virtual world, it is fitting that the 62nd ASH Annual Meeting and Exposition officially kicked off today with a virtual fireside chat via live stream featuring none other than Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, and a member of the administration’s coronavirus task force.

Engaging in virtual advocacy

LLS makes progress for blood cancer patients through virtual advocacy

Meetings with lawmakers, testimonies at state legislatures, and events with passionate volunteers are all staples of advocacy. Historically, those are some of the ways we accomplish that work. But COVID-19 prompted us to rethink the way our staff and volunteers share their message with lawmakers.

Other Disease Studies

Another type of study that blood cancer patients and their relatives can participate in is a nontherapeutic study. Nontherapeutic studies aren't considered clinical trials because they don't involve the study of new diagnostics or treatments for diseases. Instead, they're developed to gain a better understanding of disease-incidence patterns or the consequences of specific treatments for a specific disease.

In all cases, you should be asked to sign a consent form that defines the study's purpose and what's expected from the participants.

Leveraging cancer registries, clinical trials, and community partnerships to address disparities in pediatric, adolescent, and young adult lymphoma

I aim to identify drivers of pediatric and adolescent/young adult lymphoma disparities so that targeted health equity interventions can be developed. Integration of large datasets, systematic collection of social determinants data in clinical trials, and collaboration with patient advocates will: a) create new population-based resources to study lymphoma outcomes; b) establish a novel framework for equity research in lymphoma clinical trials; and c) identify real-world targets for intervention.
Marc

Marc

In 1989, Marc Smith, was diagnosed with acute myelogenous leukemia (AML). He was given a terminal prognosis and for more than two years endured numerous obstacles and setbacks, including two relapses and six extensive rounds of chemotherapy. His only chance of even short-term survival was to have a bone marrow transplant.

Madeline

Madeline

My daughter is Madeline Conley.  On January 7, 2014, three days after her 15th birthday,  she was diagnosed with leukemia (AML/MDS).  She was a high school cheerleader and cheer coach who was basically ripped out of her normal active life and immediately admitted to the hospital, where she spent the next five months. It was the scariest thing we've ever been through.

Jennifer Brenner

Jennifer

In 1985, 10-year-old Jennifer took to the stage to accept The Leukemia & Lymphoma Society’s (LLS) “Employee of the Year” award for her mother, Teresa McVay, who had lost her battle against chronic myelogenous leukemia earlier that year. That was Jennifer’s first time speaking on stage, but it would not be her last. Driven by her mother’s traumatic passing, Jennifer has been a public speaker on Adverse Childhood Events (ACEs), sharing her own experience with loss in order to bring awareness to the cause.